Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹2,291 Cr₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr
Adjustment ₹-22 Cr₹134 Cr₹102 Cr₹124 Cr₹62 Cr
Changes In working Capital ₹-200 Cr₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr
Cash Flow after changes in Working Capital ₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr
Cash Flow from Investing Activities ₹-1,415 Cr₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr
Cash Flow from Financing Activities ₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr
Net Cash Inflow / Outflow ₹72 Cr₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr
Opening Cash & Cash Equivalents ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-22 Cr₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr
Closing Cash & Cash Equivalent ₹120 Cr₹70 Cr₹132 Cr₹111 Cr₹26 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,744.4 Cr -0% -13.1% -29.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0%

-13.1%

-29.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses